From improved glycemic control and weight management to cardiovascular benefits, blood pressure regulation, and potential impacts on liver health, neuroprotection, and gastrointestinal function, semaglutide represents a multifaceted treatment option
Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials
Our mission is to empower you with the tools and information you need to build a routine you can trust
GLP-1 receptors are present in key brain regions involved in appetite regulation, including: The hypothalamus, which governs hunger and satiety signals The nucleus tractus solitarius in the brainstem, which processes signals from the gut Reward centres such as the ventral tegmental area and nucleus accumbens By activating these receptors, GLP-1 medications may reduce the rewarding properties of food and diminish food-related thoughts
Results remained stable with continued treatment